References
- Ciccarelli S , Stolfi I , Caramia G . 2013. Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infect Drug Resist. 6:133–161.
- Gerashchenko OL , Zhuravel EV , Skachkova OV , Khranovska NN , Filonenko VV , Pogrebnoy PV , Soldatkina MA . 2013. Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells. Exp Oncol. 35:76–82.
- Hazlett L , Wu M . 2011. Defensins in innate immunity. Cell Tissue Res. 343:175–188.
- Jarczak J , Kościuczuk EM , Lisowski P , Strzałkowska N , Jóźwik A , Horbańczuk J , Krzyżewski J , Zwierzchowski L , Bagnicka E . 2013. Defensins: natural component of human innate immunity. Hum Immunol. 74:1069–1079.
- Krishnakumari V , Nagaraj R . 2012. Binding of peptides corresponding to the carboxy-terminal region of human-β-defensins-1–3 with model membranes investigated by isothermal titration calorimetry. Biochim Biophys Acta. 1818:1386–1394.
- Li XZ , Nikaido H . 2009. Efflux-mediated drug resistance in bacteria: an update. Drugs. 69:1555–1623.
- Padilla E , Llobet E , Doménech-Sánchez A , Martínez-Martínez L , Bengoechea JA , Albertí S . 2010. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother. 54:177–183.
- Sass V , Pag U , Tossi A , Bierbaum G , Sahl HG . 2008. Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int J Med Microbiol. 298:619–633.
- Winter J , Wenghoefer M . 2012. Human defensins: potential tools for clinical applications. Polymers (Basel). 4:691–709.